Aviva
CLB icon

Aviva’s Core Laboratories CLB Stock Holding History

Aviva’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,328
Closed -$974K – 759
2018
Q4 		$974K Sell
16,328
-5,303
-25% -$458K 0.01% 701
2018
Q3 		$2.51M Sell
21,631
-684
-3% -$77.2K 0.01% 667
2018
Q2 		$2.82M Sell
22,315
-123
-0.5% -$15K 0.02% 640
2018
Q1 		$2.43M Sell
22,438
-2,178
-9% -$241K 0.01% 655
2017
Q4 		$2.7M Sell
24,616
-2,866
-10% -$286K 0.02% 648
2017
Q3 		$2.71M Buy
27,482
+340
+1% +$33K 0.01% 663
2017
Q2 		$2.75M Sell
27,142
-400
-1% -$43.1K 0.02% 669
2017
Q1 		$3.18M Sell
27,542
-1,536
-5% -$179K 0.02% 661
2016
Q4 		$3.49M Buy
29,078
+1,915
+7% +$212K 0.02% 639
2016
Q3 		$3.05M Buy
27,163
+635
+2% +$73.1K 0.02% 658
2016
Q2 		$3.29M Buy
26,528
+4,366
+20% +$527K 0.02% 610
2016
Q1 		$2.49M Sell
22,162
-60
-0.3% -$6.23K 0.02% 656
2015
Q4 		$2.42M Buy
22,222
+48
+0.2% +$5.5K 0.02% 672
2015
Q3 		$2.21M Sell
22,174
-868
-4% -$94.4K 0.02% 684
2015
Q2 		$2.63M Sell
23,042
-90
-0.4% -$10.9K 0.02% 672
2015
Q1 		$2.42M Buy
23,132
+5,242
+29% +$558K 0.02% 712
2014
Q4 		$2.15M Sell
17,890
-80
-0.4% -$10.5K 0.02% 705
2014
Q3 		$2.63M Sell
17,970
-20
-0.1% -$3.09K 0.02% 675
2014
Q2 		$3M Buy
17,990
+610
+4% +$109K 0.02% 641
2014
Q1 		$3.45M Buy
+17,380
New +$3.28M 0.03% 576

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Aviva's CLB Position: Q1 2019 in Review

Aviva sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 16,328 shares — an estimated $974K sold.

Aviva first reported a position in CLB in Q1 2014 and held it in 20 quarters. The position peaked at $3.49M in Q4 2016. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

  • Aviva reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
  • Aviva sold 16,328 Core Laboratories shares in Q1 2019, an estimated $974K.
  • Aviva first reported a position in Core Laboratories in Q1 2014 and held it in 20 quarters.
  • Aviva's Core Laboratories position peaked at $3.49M in Q4 2016.
  • 313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Aviva's 13F filing for Q1 2019, filed 14 May 2019.